Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) announced that as a result of a review by the British Columbia Securities Commission (BCSC), the company has decided to withdraw and refile... read more →
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) announced on Friday it filed the required Business Acquisition Reports (BAR) in relation to the company's previously announced acquisitions of Artisan Growers,... read more →
Medical Professionals are Beginning to Use Psychedelics to Treat a Host of Mental Disorders Champignon Brands is Growing a Vertically Integrated Psychedelic Drug Company Other Major Competitors Are Using Different... read more →
Novo Formulations is a Specialty Biotech Firm Currently Working with Ketamine, Anaesthetics and Adaptogenics Champignon Brands Plans to Leverage the Novo Formulations Deal to Pursue Psilocybin and MDMA Formulations Champignon... read more →
The Artisan Growers Acquisition Will Allow Champignon Brands' to Continue Accelerating its Vertical Integration Strategy Champignon Also Plans to Create the Most Compelling IP Portfolio, Clinical Pipeline and Drug Development... read more →
